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Abstract
The Lowry method and a capillary electrophoresis method were used to analyse protein residues in the supernatant after solvent deproteination 
of plasma. Acetonitrile and acetone were much more effective than methanol and ethanol at reducing the levels of proteins in plasma. The ability 
of different solvents to decrease levels of phospholipids in plasma samples was assessed using electrospray ionisation mass spectrometry (MS). 
Phospholipid signals can obscure differences between samples in general metabolite proﬁling (i.e. non-target compound) studies. Acetonitrile was 
much more effective than methanol in reducing the MS signal due to phospholipids in plasma which is a consequence of the poor solubility of 
phospholipids in acetonitrile. The capability of the solvents at reducing salts in urine samples was also studied by using an amperometric method. 
Using this approach little difference was detected between methanol, ethanol, acetonitrile and acetone in their ability to desalt urine samples. 
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1. Introduction
The analysis of biological samples using liquid chromatog­
raphy coupled with mass spectroscopy detection (LC–MS), 
in particular for metabolite proﬁling studies, requires protein-
free and/or salt-reduced preparations [1,2]. Metabonomics is 
an example of proﬁling studies concerned with ﬁnding the 
variability in metabolites among a collection of biological sam­
ples, followed by classiﬁcation of the samples according to 
any revealed variability. Besides ultraﬁltration and solid phase 
water-miscible organic solvent might be the best method prior to 
liquid chromatography mass spectrometry because it decreases 
electrolytes instead of increasing them. This should improve the 
MS sensitivity and avoid instrument capillary blockage. In addi­
tion, solvent deproteination has the advantage of better analyte 
recovery over the other methods [3,4]. In case of urine samples, 
some researchers prefer to reduce the salt in samples by further 
diluting them with water or with any water-miscible solvent [10]. 
In addition to removing proteins and salts from biological 
samples, we have found during our metabonomic studies that it 
extraction, which are expensive and low-recovery deproteina- is also often essential to remove phospholipids or to reduce their 
tion procedures [3], precipitation of proteins from serum or original concentrations because their strong signals may obscure 
plasma samples can be carried out by adding salts, some acids other more important biomarkers and they tend to appear as 
background peaks throughout the chromatogram. In addition, 
they lack the reproducible responses required in MS analysis 
by nuclear magnetic resonance (NMR) spectroscopy, addition of [11]. They might be consequently considered as false biomark­
ers by the statistical tools used for calculating the variability 
among biological samples as part of proﬁling studies. Added to 
this the phospholipids’ ionic character can lead to further ion 
suppression during mass spectroscopy (MS) analysis [12]. 
or water-miscible organic solvents [3–9]. Although all of these 
procedures can be used in discarding proteins prior to analysis 
In order to assess the effect of the solvent on the biologi­
cal sample composition, four semipolar solvents were used in 
this study, namely: methanol, ethanol, acetone and acetonitrile. 
A number of publications have mentioned comparing studies 
of analyte recovery using different semipolar solvents, but little 
data are reported on the evaluation of solvents for removing 
undesirable biological molecules before introducing samples 
into the LC–MS systems. 
The Lowry test, a colorimetric protein-general test was used 
to measure all types of protein remaining in the sample liquor 
after discarding the majority of the proteins [13–16]. Capillary 
electrophoresis (CE) can be used to carry out more speciﬁc pro­
tein analysis [17–21] and in the current work was able to resolve 
the albumin peak as a major protein from the other proteins 
in the deproteinated plasma samples. However, the semipolar 
solvents precipitated certain amounts of salts from the urine 
samples; the remaining salts in the sample supernatant would be 
expected to govern the electrical current properties of the ﬁnal 
preparation after subtracting the blank contribution. Integrated 
mode pulse amperometry was chosen to measure the amount 
of salt remained in the samples because it is possible to hold 
the integration period of the current induced by salts at a con­
stant potential for a certain time period during the pulse [22]. 
Then the waveform ﬁnishes with a reductive potential in order 
to clean away any oxides accumulated over the gold electrode 
during the course of the measurements [23,24]. Additionally, the 
integrated mode of detection provides a compensatory mecha­
nism for any likely aging of the electrode during the analysis 
period [23]. Finally, Soya lecithin, which is a common phos­
pholipid standard material [25–28] was mixed with a constant 
volume of each semipolar solvent under controlled conditions, 
in order to measure the solubility of lecithin in each solvent. 
The weight difference between the undissolved lecithin before 
and after the experiment was utilized to measure phospholipids’ 
solubility in each solvent. The results are also supported by a 
mass spectrometry infusion study. 
In this work, common water-miscible solvents were com­
pared according to their ability in removing proteins, salts and 
phospholipids from the plasma and urine. Protein removal from 
plasma samples was analysed by using the Lowry method and 
a capillary electrophoresis (CE) method. The urine desalting 
ability of the solvents was evaluated by an integrated pulse 
amperometry technique. Finally, gravimetric analysis and direct 
infusion into the mass spectrometer were used in evaluating the 
remaining phospholipid content in the samples. 
2. Experimental
2.1. Chemicals and materials
Methanol, acetonitrile, formic acid (98%) and water of HPLC 
grade were purchased from VWR International Ltd. (Lutter­
worth, UK). Acetone, absolute ethanol and sodium hydroxide 
pellets were purchased from Riedel-deHaen¨ (Germany). 
Hexadimethrine bromide (polybrene), ammonium formate 
97%, bovine serum albumin, copper(II) sulphate hydrate, Folin­
Ciocalteu’s phenol reagent 2 N, potassium sodium (+)-tartarate, 
l-�-phosphatidyl choline (l-�-Lecithin) Type IV-S from soy­
abean, sodium chloride and sodium carbonate were purchased 
from Sigma–Aldrich (Poole, UK). Syringe ﬁlters 4 mm in 
diameter with 0.45 �m pore size, a PVDF membrane and a 
polypropylene housing having only 0.125 cm2 surface area 
were purchased from Whatman International Ltd. (England). 
Polyvar Microscope (Leica, Germany) was used to examine the 
precipitate under bright ﬁeld light. Pictures were taken by the 
colour video digital camera JVC TK-12080E (JVC, Japan). 
Blank plasma samples were obtained from the blood bank 
at Gartnavel General Hospital (Glasgow, UK), and stored at 
−20 ◦C prior to use. 
2.2. Capillary electrophoresis (CE) and Lowry test
A HP 3D CE capillary electrophoresis unit was used with 
Chemstation® software version 10.03 for data acquisition (Agi­
lent Technologies, Waldbronn, Germany) equipped with a UV 
diode array detector. The UV detection was carried out at a wave­
length of 206 nm. The cell bandwidth was 4 nm. The applied 
voltage was set at 12 kV, the separation was carried out under 
a negative polarity mode (i.e. from negative to positive), and 
injection was carried out hydrodynamically at 50 mbar pres­
sure for 3 s. The column used was a bare fused silica capillary 
(Polymicro Technologies, Phoenix, AZ, USA) having an inter­
nal diameter of 50 �m, a total length of 33.5 cm and effective 
length of 25 cm. The temperature of the column was kept con­
stant at 25 ◦C during the analysis period. Prior to analysis, the 
column was ﬂushed for 10 min with a 0.25 M NaOH solution 
followed by a 10 min ﬂush with ammonium formate buffer 
(25 mM, pH 3.5). Finally the column was ﬂushed for 15 min 
with polybrene, a polycationic polymer (1%, w/v solution), 
for coating the silica surface, followed by a ﬁnal ﬂush with 
ammonium formate buffer (25 mM, pH 3.5) for 10 min. The 
Lowry test was carried out according to its original reference 
[29]. 
2.3. Sample preparation for analysis by capillary
electrophoresis (CE)
Plasma (0.3 ml) was vortexed in a 1.5 ml eppendorf tube 
with the same volume as one of the water-miscible sol­
vents. The samples were centrifuged for 10 min at room 
temperature and 7000 rpm. Following this 0.3 ml from the 
supernatant was mixed with 0.7 ml of distilled water. Excep­
tionally, the samples treated with either ethanol and methanol 
were further diluted 25 times with distilled water. Then 
they were ﬁltered through 0.45 �m syringe ﬁlters. Standard 
preparations were made by dissolving bovine serum albu­
min in distilled water to achieve the following concentrations: 
0.8, 0.16, 0.032 and 0.006 mg/ml. 
2.4. Determination of phospholipid solubility
The experiment was carried out in a Clifton water bath 
equipped with a shaking stage. The parameters were 25 ± 1 ◦C 
and 300 St/min. Twelve 5 ml dried and screw-capped glass vials 
were weighed and labelled according to the samples’ ID. 100 mg 
of lecithin was added into each glass vial with 2 ml of a water-
miscible organic solvent, the capped vials were enveloped with 
paraﬁlm sheets, and then the samples were immersed in a suit­
able rack into the water bath. 
The samples were shaken for 30 min, then removed from the 
water bath and their external surfaces wiped clean. Previously 
weighed ﬁlter caps (made in-house) were substituted with the 
original vial caps and the solutions were ﬁltered with the aid of 
suction. Subsequently, the vials and caps were left under a fume 
hood overnight to guarantee drying to completion. Finally they 
were weighed to establish the weight of undissolved lecithin in 
each sample, which was then subtracted from the original weight 
in order to calculate the amount of phospholipid dissolved in 2 ml 
of solvent. 
The results of the solubility experiment were supported by 
analysing plasma samples using direct infusion mass spec­
trometry (LCQ, Finnigan Mat). The analysis was carried out 
by using electropray ionisation in the positive mode with a 
capillary temperature of 250 ◦C, sheath gas ﬂow 40 ml/min, 
zero auxiliary gas and scan range (150–2000)m/z. The infu­
sion ﬂow was 10 �l/min. The data of 32 scans was averaged 
for each sample. Twelve plasma samples were prepared from 
the same plasma stock by adding 100 �l into a 1.5 ml eppen­
dorf tube and then the same volumes of either acetonitrile 
or methanol were added into the sample tube. Then the 
contents was vortex centrifuged for 10 min at 7000 rpm. Fol­
lowing this 100 �l of the supernatant was diluted to 1 ml 
using either acetonitrile or methanol. Finally, the samples 
were ﬁltered through 0.45 �m syringe ﬁlters before infusion 
into the MS system. Lecithin reference solution was pre­
pared by dissolving lecithin in methanol to a concentration of 
1 �g/ml. 
2.5. Comparison of salt content in the urine following
addition of water-miscible organic solvents
The urine samples were collected from source and kept 
in the freezer at −20 ◦C until use. The stock urine sam­
ples were thawed then centrifuged at 2 ◦C for 10 min and 
4000 rpm to remove suspended particles and salt agglomerates. 
The supernatants were taken up immediately, and then super­
natants were kept on the bench for 15 min to equilibrate to 
room temperature. 0.5 ml of the solvents was added to 0.5 ml 
of each urine sample. Subsequently, each sample was vortex 
mixed and centrifuged for 10 min at 4000 rpm. Then 0.25 ml 
of the resultant solution was diluted to a total volume of 25 ml 
with HPLC grade water. For each solvent three samples were 
prepared. 
Blank samples were also prepared according to the same pro­
cedure but 0.5 ml of HPLC grade water was used instead of urine. 
An ED 50 electrochemical detector (Dionex, UK) equipped with 
a titanium-body amperometry cell with a gold working elec­
trode and Ag/AgCl reference electrode was used in integrated 
amperometry mode. The waveform was selected to apply a con­
stant potential during the integration period and to end up with 
a reducing potential for cleaning the working electrode from the 
oxidised materials. To obtain the results as an area under the 
curve (AUC) for the detector signals, the detector was attached 
with a Spectra System P100 HPLC pump (Spectra-Physics) ﬁt­
ted with a 20 �l loop Rheodyne injector, and with a DP700 
integrator (Fisons instruments). During the analysis, the pump 
ﬂow rate was maintained at 1 ml/min of HPLC water. Standard 
solutions of sodium chloride in HPLC water with concentrations 
0.2–10 mg/100 ml were prepared. 
3. Results and discussion
3.1. Protein determination
In the CE analysis the experimental parameters and con­
ditions were selected carefully to prevent adsorption of large 
proteins like albumin onto the surface of the fused silica 
capillary. In order to accomplish this, polybrene, which is a 
pH-independent cationic polymer, was used to coat the inner 
wall of the silica capillary, and the pH of the analysis buffer 
ensured that albumin, which has an isoelectric point of 4.9 
[30], was positively charged during the analysis. Fig. 1 shows 
a good peak shape for both bovine serum albumin (BSA) in 
the standard preparation and human serum albumin (HSA) in 
some of the precipitated plasma test solutions. The BSA peak 
migrated slightly earlier than HSA due to some slight struc­
tural differences between the proteins. The humps preceding 
the albumin peak are interpreted as other proteins present in 
the plasma. The Lowry test, which is a general spectrophoto­
metric protein test, was used to quantify total protein in the 
plasma samples. Although the plasma samples deproteinated 
by methanol and ethanol were 25 times more dilute than the 
samples treated by either acetone or acetonitrile, the albu­
min peaks were still larger in the case of both methanol and 
ethanol. Albumin is the main protein in the plasma [30] and 
it is clear from the electropherograms in Fig. 1 that acetonitrile 
and acetone are much stronger deproteinisers than methanol and 
Fig. 1. Capillary electrophoresis traces showing the amount of HSA left in 
plasma following treatment with different water-miscible solvents in comparison 
with a BSA standard. 
Fig. 2. Microscope picture of protein precipitated from plasma by acetonitrile 
(1:1). The precipitate forms an agglomerate. 
ethanol. Acetonitrile and acetone have higher dielectric con­
stant in comparison with methanol and ethanol [31] and lower 
viscosity. These two physical parameters control the associa­
tion and dissociation forces between water and organic solvents 
on the one hand, and between proteins and solvent mixtures 
on the other. This will lead to different precipitation mecha­
nisms for proteins according to the solvent used. Fig. 2 shows 
a microscopical image for a plasma sample treated with ace­
tonitrile where the precipitation appears as a well-compacted 
mass, while methanol (Fig. 3) produces a precipitation like a 
ﬁne suspension. The amount of albumin remaining in the sam­
ple supernatant after precipitating 1 ml of plasma with 1 ml of the 
solvent according to analysis by CE was 23 mg/ml for methanol 
and 18 mg/ml for ethanol, while the concentration was below 
the limit of detection (6.4 �g/ml) in the case of acetonitrile and 
acetone. 
The Lowry test is widely used for protein analysis [32]. 
BSA Standard solutions showed good linearity within the range 
25–200 �g/ml. According to this test the amount of protein 
remaining in 1 ml plasma supernatant, treated with the same 
volume of methanol, ethanol, acetone and acetonitrile, was cal-
Fig. 3. Microscope picture of protein precipitated from plasma by methanol 
(1:1). The precipitate forms small particles. 
Fig. 4. Solubility of lecithin in four different water-miscible solvents. 
culated to be 22.5, 15.7, 2.7 and 2.25 mg/ml, respectively. The 
results of this test are not far from those taken from the elec­
trophoretic analysis. This is expected because the albumin is the 
dominant protein in plasma [3]. In conclusion, acetone and ace­
tonitrile are much better than methanol and ethanol for protein 
elimination from plasma samples. 
Fig. 5. Comparison of phospholipid mass spectral intensity for plasma samples treated with acetonitrile or with methanol. 
3.2. Phospholipid determination
Lecithin, which is used as a standard for the analysis of phos­
pholipids, is a complex mixture [25]. Its components lack a 
distinct chromophore. Thus gravimetry was chosen as a method 
for assessing phospholipid solubility in the water-miscible sol­
vents. This solubility experiment was designed to make sure 
that the sample vials and their caps were weighed at the begin­
ning and at the end of the experiment in order to subtract their 
weights upon calculation of the amount of undissolved lecithin. 
The amount of lecithin dissolved in methanol, ethanol, acetone 
or acetonitrile was calculated by taking the difference of lecithin 
weight remaining in the samples after carrying out the solubil­
ity study and the original weight of lecithin in each sample. The 
results are shown in Fig. 4. The solubility of lecithin in methanol 
under the described conditions was 22.3 mg/ml and in acetoni­
trile was 0.12 mg/ml. In order to conﬁrm the results obtained 
on the solubility of phospholipids, plasma samples precipitated 
with either methanol or acetonitrile were infused into the mass 
spectrometer. The total intensity response plot for plasma sam­
ples (Fig. 5) shows that the plasma samples precipitated with 
methanol have much higher response for the phospholipid ions, 
which dominate in the total ion count (TIC) in comparison with 
those treated with acetonitrile. Moreover, it is shown in Fig. 6 
that the vast majority of peaks in the infused plasma sample 
charts are related to phospholipids; lecithin standard solution 
showed four main peak clusters, around 500, 800, 1300 and 
1600m/z. The peaks around 500 and 800m/z are for phospho­
lipid monomers and those around 1300 and 1600m/z are due 
to hetero- and homodimers of the phospholipid molecules. The 
large peak clusters observed in plasma samples are located at 
the same mass ranges as those in the lecithin standard. Acetoni-
Fig. 6. Direct infusion mass spectra: (A) phospholipids in lecithin, (B) phospho­
lipids in methanol treated plasma and (C) phospholipids in acetonitrile treated 
plasma. 
Fig. 7. Peaks obtained from urine samples treated with different organic solvents 
using an ED50 amperometric detector. Blank solutions have a small negative 
response, while the sample and the standard have clear positive peaks. 
trile precipitated plasma has low responses in the region around 
1300 and 1600m/z. This might be explained by the fact that, 
acetonitrile has slightly higher dielectric constant and lower vis­
cosity than methanol. This will improve droplet dispersion in the 
electrospray ionization (ESI) process [31] thus reducing cluster 
formation. 
3.3. Salt determination
The ED50 detector was used to measure the amount of salt 
in the urine following treatment with one of the water-miscible 
solvents. The peak areas obtained (Fig. 7) were used to measure 
the salt content. Blank samples show small negative peaks par­
ticipating in measurement error, which was not exceeding 5%. 
The linearity between the concentration of salt and the response 
by using ten different concentrations of sodium chloride was lin­
ear in a narrow range 1–5 mg%, so the test samples were diluted 
to have peak areas within this range. If the average response of 
acetone-desalted samples is assumed to be 100%, then acetoni­
trile, methanol and ethanol possessed 101.3, 79.6 and 80.9%, 
respectively. Thus methanol and ethanol show slightly higher 
desalting ability. 
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